YH ENT (02306) repurchased 30,000 shares for a total of HKD 18,600 on February 7th.

07/02/2025

GMT Eight

YH ENT (02306) announced on February 7, 2025 that the company will spend HKD 18,600 to repurchase 30,000 shares at a repurchase price of HKD 0.62 per share.

Dong-E-E-Jiao (000423.SZ) shareholder CHINARES PHARMA has increased its holdings by 1% in cumulative investments.

CSI PROPERTIES (00497): Wong Ho Yi appointed as Group Chief Financial Officer

Contact: contact@gmteight.com

YH ENT (02306) repurchased 30,000 shares for a total of HKD 18,600 on February 7th.

RECOMMEND

Fengxing Co., Ltd. (002760.SZ): Jiangxi Taihao collectively reduces holdings of 900,000 shares.

Shenzhen FRD Science & Technology (300602.SZ): Some shareholders plan to reduce their holdings by a total of no more than 1,255,000 shares.

J. Pond Precision Technology (301326.SZ) : significantly raised the repurchase price limit to 95 yuan/share.